Gadolinium-based contrast agents (GBCAs) are used in some MRI’s. In 2006, it was discovered that GBCAs could cause a horrifying, and sometimes fatal, condition called Nephrogenic Systemic Fibrosis (NSF) in people with impaired kidney function, although the first cases were seen as early as 1997. Over time it became clear that GBCAs can cause a very serious condition in people with normal kidney function. Gadolinium deposition disease occurs when gadolinium breaks free of its chelator and is deposited in the body instead of being cleared by the kidneys. It is more common when linear GBCA is used.
Gadolinium Deposition Disease
Gadolinium is a highly toxic heavy metal. It must be chelated when used in the body. In macrocyclic GBCAs gadolinium is bound are bound more tightly to its chelator than in linear GBCAs. Linear GBCAs are less stable. The gadolinium can break free and deposit in the body causing gadolinium toxicity.
The symptoms of gadolinium deposition disease (GDD) can begin from within hours to two months of administration, and include:
- Intense burning sensation in the skin
- Excruciating pain, often describe as pins and needles, cutting or burning
- Intense bone or joint pain – in any bones or joint, but often rib pain
- Headache – often describe as a burning pain or feeling of tightness
- Neck pain
- Pain and a thickening appearance of the tendons and ligaments
- Tightness in the hands and feet
- Muscle twitches
- Brain fog or “chemo brain”
- Pinkness to the skin
- Thickening of the skin giving it a doughy texture
- Stiffness in the joints
- Decreased range of motion
Additionally, people with gadolinium toxicity have reported symptoms including:
- Itchy skin
- Hair loss
- Fatigue
- Difficulty breathing
- Tremors
- Nausea and/or vomiting
- Diarrhea
- Hearing problems
- Vision problems
If you have developed symptoms of GDD after MRI, please talk to an experienced defective drug attorney right away to learn more about your rights.
How many millions have been given mast cell disease, lupus, fibromyalgia and Sclerosis from this poison?
Sandra: It would really be appreciated, especially by those poisoned by macrocyclic agents, if you would treat both types of contrast equally. Macrocyclics may take a little longer to lose its chelator, but we are finding the possibility that the intact chelator being more damaging. By inferring the linear to be more dangerous because of its instability, you are perpetuating the drug manufacturer’s myth so they may continue poisoning with the “safer” macrocyclic agents. They are both bad. Thank you.
Excellent information Debi! The world needs to know that zero gadolinium should be found in the human body!
Debi; I have just been declined for legal support because two of the 3 MRI ‘s I had were not macrocyclic and one being linear. I progressively worsened after each treatment. I am now pretty much bedridden. Please make sure people understand that the gadolinium saturation is most likely additive with each exposure no matter the type.
Hello Marjorie:
You are not alone. Many people who have signed retainer agreements with law firms are being dropped for idiotic and nonsensical reasons. Something smells with these so called gadolinium lawsuits. You are also correct; gadolinium retention is cumulative after each dose.
Please take care of yourself.
Debi